ABSTRACT
It is an understatement to describe medical product development as a highly complex process. Once research has established “proof of principle,” great care should be taken to comply with the labyrinth of requirements of regulatory authorities to develop a clinically useful product. e written and verbal guidance of regulatory authorities is applicable to each step along the way.
